Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 May 8;8(1):291–301. doi: 10.3892/etm.2014.1704

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014, Spandidos Publications

This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.

PMC Copyright notice

Cell survival curves for the total cell population from B16-BL6 tumors irradiated with reactor neutron beams following the administration of a ¹⁰B-carrier in combination with nicotinamide treatment, mild temperature hyperthermia (MTH), or bevacizumab treatment on day 18 following tumor cell inoculation. Open and solid symbols represent irradiation without and with bevacizumab, respectively. Circle, square, and triangle symbols represent irradiation without nicotinamide or MTH, with nicotinamide, and with MTH, respectively. Bars represent standard errors (n=9). ¹⁰B (−), no ¹⁰B-carrier; BPA, L-para-boronophenylalanine-¹⁰B; BSH, sodium mercaptoundecahydrododecaborate-¹⁰B; MTH, mild temperature hyperthermia; BV, bevacizumab.